Once CTCL has been diagnosed, your doctor will consider both the stage of your disease and the symptoms you have, in order to determine the best treatment.
In the past 2 decades, several new therapies have become available to treat CTCL.
Keep in mind, that no single therapy is effective in all patients. Only your doctor can determine which treatment is best for you and the order in which you receive these treatments. Your doctor may also prescribe multiple treatments, including those listed below, to treat your CTCL. This list is not comprehensive; some therapies may not be listed below.
Specially designed for medical professionals to use in their practice.
See top Opinion Leaders address FAQs about THERAKOS™ Photopheresis
Methoxsalen Sterile Solution is indicated for extracorporeal administration with the THERAKOS™ UVAR XTS® or THERAKOS™ CELLEX® Photopheresis System in the palliative treatment of the skin manifestations of cutaneous T-cell lymphoma (CTCL) that is unresponsive to other forms of treatment.
Methoxsalen is not appropriate for patients who have had a reaction to psoralen compounds, patients who have had a light sensitive disease, or patients with an absence of one or both lenses of the eye.
THERAKOS™ Photopheresis is not appropriate for patients who cannot tolerate blood volume changes or patients with blood clotting disorders. See Important Safety Information for additional details.